"Analysis.group","Analysis.number","Analysis.name","Subgroup","Subgroup.number","Applicability","Study","Study.year","GIV.Mean","GIV.SE","Experimental.mean","Experimental.SD","Experimental.cases","Experimental.N","Control.mean","Control.SD","Control.cases","Control.N","O.E","Variance","Weight","Mean","CI.start","CI.end","Footnotes","Bias.arising.from.the.randomization.process.judgement","Bias.arising.from.the.randomization.process.support","Bias.due.to.deviations.from.intended.interventions.judgement","Bias.due.to.deviations.from.intended.interventions.support","Bias.due.to.missing.outcome.data.judgement","Bias.due.to.missing.outcome.data.support","Bias.in.measurement.of.the.outcome.judgement","Bias.in.measurement.of.the.outcome.support","Bias.in.selection.of.the.reported.result.judgement","Bias.in.selection.of.the.reported.result.support","Overall.bias.judgement","Overall.bias.support","review.url","review.doi","analysis_key","dataset_name","mismatch_type","direction_match","or_sig","rd_sig","log_or","rd","log_or_ci_lb","log_or_ci_ub","rd_ci_lb","rd_ci_ub","sparse_events","double_zero"
1,1,"Incidence of herpes zoster (up to 21 months after final dose)",NA,NA,"SUBGROUP_AND_OVERALL","Dagnew 2019",2019,0,0.763637241789639,0,0,2,259,0,0,14,256,0,0.583141837048087,41.664144,0.141202,0.032418,0.615038,"Herpes zoster was confirmed by skin lesion PCR, or by adjustication of the clinical case description","Low risk","<p>Participants were randomised via an online centralised randomisation system and the allocation sequence was concealed. There are no baseline differences that would suggest a problem with randomisation.</p>","Low risk","<p>Both participants and those delivering the intervention were unaware of the assigned intervention received and the analysis was probably appropriate.</p>","Low risk","<p>Data for this outcome was available for 515 out of 569 participants randomised. Reasons for exclusions provided and similar for both groups.</p>","Low risk","<p>The measurement of the outcome was appropriate and it is unlikely that it differed between intervention groups. The outcome assessors were unaware of the intervention received.</p>","Some concerns","<p>The reported analysis was a post hoc analysis defined by protocol amendment. There was no indication for selection among multiple measurements or analyses.</p>","Some concerns","<p>For this outcome, there is a low risk of bias from the randomization process, due to deviations from intended interventions, due to missing outcomes and due to measurement of the outcome. However, there are some concerns for bias due to selection of the reported results.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015530.pub2/full","10.1002/14651858.CD015530.pub2","1::overall","CD015530_pub2_data","significance_only",TRUE,FALSE,TRUE,-0.579895851608645,-0.0224890992813187,-1.19013980125461,0.0303480980373239,-0.0435254584093989,-0.00145274015323854,TRUE,FALSE
1,1,"Incidence of herpes zoster (up to 21 months after final dose)",NA,NA,"SUBGROUP_AND_OVERALL","Mullane 2019",2019,0,0.173088689735248,0,0,58,1277,0,0,70,1275,0,0.029959694514265,58.335856,0.827274,0.589272,1.161402,"Herpes zoster was confirmed by skin lesion PCR, or by adjustication of the clinical case description","Low risk","<p>Participants were randomised via central randomisation schedules by the trial statistician and the allocation sequence was concealed. There are no baseline differences that would suggest a problem with randomisation.</p>","Low risk","<p>Both participants and those delivering the intervention were unaware of the assigned intervention received and the analysis was appropriate.</p>","Low risk","<p>Data for this outcome was available for 2552 out of 2573 participants randomised.</p>","Low risk","<p>The measurement of the outcome was appropriate and it is unlikely that it differed between intervention groups. The outcome assessors were unaware of the intervention received.</p>","Some concerns","<p>We have some concerns regarding selection of the reported results because trial was terminated early in this population and all outcomes were deemed exploratory by protocol amendment. There was no indication for selection among&nbsp;</p>","Some concerns","<p>For this outcome, there is a low risk of bias from the randomization process, due to deviations from intended interventions, due to missing outcomes and due to measurement of the outcome. However, there are some concerns for bias due to selection of the reported results.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015530.pub2/full","10.1002/14651858.CD015530.pub2","1::overall","CD015530_pub2_data","significance_only",TRUE,FALSE,TRUE,-0.579895851608645,-0.0224890992813187,-1.19013980125461,0.0303480980373239,-0.0435254584093989,-0.00145274015323854,TRUE,FALSE
1,3,"Adverse events of any grade (up to 30 days after final dose)",NA,NA,"SUBGROUP_AND_OVERALL","Dagnew 2019",2019,0,0,0,0,134,283,0,0,128,279,0,0,6.956333,1.032078,0.864636,1.231946,"","Low risk","<p>Participants were randomised via an online centralised randomisation system and the allocation sequence was concealed. There are no baseline differences that would suggest a problem with randomisation.</p>","Low risk","<p>Both participants and those delivering the intervention were unaware of the assigned intervention received and the analysis was probably appropriate.</p>","Low risk","<p>Data for this outcome was available for 562 out of 569 participants randomised. Reasons for exclusions provided and similar for both groups.</p>","Low risk","<p>The measurement of the outcome was appropriate and it is unlikely that it differed between intervention groups. The outcome assessors were unaware of the intervention received.</p>","Low risk","<p>The reported analyses were pre-defined at protocol stage. There was no indication for selection among multiple measurements or analyses.</p>","Low risk","<p>For this outcome, there was a low risk of bias for all the domains.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015530.pub2/full","10.1002/14651858.CD015530.pub2","3::overall","CD015530_pub2_data","significance_only",TRUE,TRUE,FALSE,0.331442106930818,0.0403873211988607,0.01378434376627,0.649099870095365,-0.0187828347490553,0.0995574771467766,FALSE,FALSE
1,3,"Adverse events of any grade (up to 30 days after final dose)",NA,NA,"SUBGROUP_AND_OVERALL","Mullane 2019",2019,0,0,0,0,1030,1274,0,0,911,1274,0,0,93.043667,1.130626,1.082206,1.181212,"","Low risk","<p>Participants were randomised via central randomisation schedules by the trial statistician and the allocation sequence was concealed. There are no baseline differences that would suggest a problem with randomisation.</p>","Low risk","<p>Both participants and those delivering the intervention were unaware of the assigned intervention received and the analysis was appropriate.</p>","Low risk","<p>Data for this outcome was available for 2548 out of 2573 participants randomised.</p>","Low risk","<p>The measurement of the outcome was appropriate and it is unlikely that it differed between intervention groups. The outcome assessors were unaware of the intervention received.</p>","Some concerns","<p>We have some concerns regarding selection of the reported results because trial was terminated early in this population and all outcomes were deemed exploratory by protocol amendment. There was no indication for selection among&nbsp;</p>","Some concerns","<p>For this outcome, there is a low risk of bias from the randomization process, due to deviations from intended interventions, due to missing outcomes and due to measurement of the outcome. However, there are some concerns for bias due to selection of the reported results.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015530.pub2/full","10.1002/14651858.CD015530.pub2","3::overall","CD015530_pub2_data","significance_only",TRUE,TRUE,FALSE,0.331442106930818,0.0403873211988607,0.01378434376627,0.649099870095365,-0.0187828347490553,0.0995574771467766,FALSE,FALSE
2,1,"Incidence of COVID-19 (up to 6 months after second dose) ",NA,NA,"SUBGROUP_AND_OVERALL","Thomas 2022",2022,0,0,0,0,1,45,0,0,1,50,0,0,0,1.111111,0.071573,17.248999,"","Low risk","<p>Participants were randomised via the use of an IRT system and the allocation sequence was concealed. There are no baseline differences that would suggest a problem with randomisation.</p>","Low risk","<p>Both participants and those delivering the intervention were unaware of the assigned intervention received and the analysis was probably appropriate.</p>","Low risk","<p>Data for this outcome was available for 45 participants in the intervention group and 50 participants in the control group. There is no evidence that the result was not biased by missing data, but it is unlikely that missingness depend on its true value.</p>","Low risk","<p>The measurement of the outcome was appropriate and it is unlikely that it differed between intervention groups. The outcome assessors were unaware of the intervention received.</p>","Some concerns","<p>We have some concerns regarding selection of the reported results because of post hoc subgroup analyses that were not pre-defined at protocol stage. There was no indication for selection among multiple measurements or analyses.</p>","Some concerns","<p>For this outcome, there is a low risk of bias from the randomization process, due to deviations from intended interventions, due to missing outcomes and due to measurement of the outcome. However, there are some concerns for bias due to selection of the reported results.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015530.pub2/full","10.1002/14651858.CD015530.pub2","1::overall","CD015530_pub2_data","significance_only",TRUE,FALSE,TRUE,-0.579895851608645,-0.0224890992813187,-1.19013980125461,0.0303480980373239,-0.0435254584093989,-0.00145274015323854,TRUE,FALSE
2,3,"Serious adverse events (up to 6 months after second dose)",NA,NA,"SUBGROUP_AND_OVERALL","Thomas 2022",2022,0,0.197410197443526,0,0,28,1182,0,0,19,1146,0,0.0389707860546917,100,1.4288,0.802494,2.543909,"Participants with a malignancy at baseline (past or ongoing) including haematological malignancies and solid toumors","Low risk","<p>Participants were randomised via the use of an IRT system and the allocation sequence was concealed. There are no baseline differences that would suggest a problem with randomisation.</p>","Low risk","<p>Both participants and those delivering the intervention were unaware of the assigned intervention received and the analysis was probably appropriate.</p>","Low risk","<p>No flow chart provided. There is no evidence that the result was not biased by missing data, but it is unlikely that missingness depend on its true value.</p>","Low risk","<p>The measurement of the outcome was appropriate, and it is unlikely that it differed between intervention groups. The outcome assessors were unaware of the intervention received.</p>","Some concerns","<p>We have some concerns regarding selection of the reported results because of post hoc subgroup analyses that were not pre-defined at protocol stage. There was no indication of selection among multiple measurements or analyses.</p>","Some concerns","<p>For this outcome, there is a low risk of bias from the randomization process, due to deviations from intended interventions, due to missing outcomes and due to measurement of the outcome. However, there are some concerns for bias due to selection of the reported results.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015530.pub2/full","10.1002/14651858.CD015530.pub2","3::overall","CD015530_pub2_data","significance_only",TRUE,TRUE,FALSE,0.331442106930818,0.0403873211988607,0.01378434376627,0.649099870095365,-0.0187828347490553,0.0995574771467766,FALSE,FALSE
3,1,"Incidence of COVID-19 (up to median 3.1 months from vaccination)",NA,NA,"SUBGROUP_AND_OVERALL","Barbui 2022",2022,0,0,0,0,10,287,0,0,8,131,0,0,0,0.570557,0.230484,1.412401,"","","","","","","","","","","","","","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015530.pub2/full","10.1002/14651858.CD015530.pub2","1::overall","CD015530_pub2_data","significance_only",TRUE,FALSE,TRUE,-0.579895851608645,-0.0224890992813187,-1.19013980125461,0.0303480980373239,-0.0435254584093989,-0.00145274015323854,TRUE,FALSE
4,1,"Incidence of influenza (within the 2015 to 2016 flu season)",NA,NA,"SUBGROUP_AND_OVERALL","Branagan 2016",2016,0,0,0,0,3,74,0,0,4,48,0,0,0,0.486486,0.113864,2.078533,"","Some concerns","<p>There were no further information given on the randomization process and on the allocation concealment. There are no baseline characteristics provided.</p>","Low risk","<p>Both participants and those delivering the intervention were probably unaware of the assigned intervention received and the analysis was probably appropriate.</p>","Low risk","<p>Data for this outcome was available for all 122 participants randomised.</p>","Low risk","<p>The measurement of the outcome was probably appropriate and did not differ between intervention groups. The outcome assessors were probably unaware of the intervention received.</p>","Some concerns","<p>The statistical analysis plan and study protocol are not available.</p>","Some concerns","<p>For this outcome, there is a low risk of bias due to deviations from intended interventions, due to missing outcomes and due to measurement of the outcome. However, there are some concerns for bias from the randomization process and due to selection of the reported results.</p>","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015530.pub2/full","10.1002/14651858.CD015530.pub2","1::overall","CD015530_pub2_data","significance_only",TRUE,FALSE,TRUE,-0.579895851608645,-0.0224890992813187,-1.19013980125461,0.0303480980373239,-0.0435254584093989,-0.00145274015323854,TRUE,FALSE
